MR-Parkinsonism

MR-Parkinsonism computes the Magnetic Resonance Parkinsonism Index (MRPI) from MRI to quantify brainstem morphometry for distinguishing progressive supranuclear palsy (PSP) subtypes, including PSP-Richardson's syndrome and PSP-parkinsonism.

Key Features:

• Automated Calculation: Calculates MRPI values from MRI-derived measurements of brainstem structures using automated processing.
• High Diagnostic Accuracy: Differentiates PSP-Richardson's syndrome and PSP-parkinsonism from non-PSP participants with reported accuracies of 93.6% and 86.5%, respectively, and identifies early-stage PSP with accuracies of 90.1% and 85.9%, respectively.
• Generalizability: Validated in a large international cohort to support applicability across diverse populations.

Scientific Applications:

• Differential Diagnosis: Distinguishing PSP-Richardson's syndrome and PSP-parkinsonism from non-PSP conditions using MRPI morphometric markers.
• Early-stage Detection: Identifying early-stage PSP cases based on MRPI values.
• Biomarker Standardization: Providing a standardized morphometric biomarker for international PSP research cohorts.

Methodology:

Uses MRI slices focusing on brainstem structures, including parasagittal views of the middle cerebellar peduncle and coronal oblique reconstructions of superior cerebellar peduncles, to calculate MRPI values.